Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023

BUY
$9.99 - $18.71 $99,310 - $185,996
9,941 Added 302.53%
13,227 $245,000
Q2 2023

Aug 07, 2023

SELL
$9.17 - $19.29 $79,962 - $168,208
-8,720 Reduced 72.63%
3,286 $36,000
Q1 2023

May 02, 2023

SELL
$12.53 - $21.71 $63,903 - $110,721
-5,100 Reduced 29.81%
12,006 $161,000
Q4 2022

Jan 30, 2023

SELL
$11.61 - $16.11 $150 - $209
-13 Reduced 0.08%
17,106 $212,000
Q3 2022

Nov 08, 2022

BUY
$12.21 - $19.7 $1,025 - $1,654
84 Added 0.49%
17,119 $239,000
Q2 2022

Aug 04, 2022

SELL
$11.23 - $19.59 $26,895 - $46,918
-2,395 Reduced 12.33%
17,035 $235,000
Q1 2022

May 05, 2022

BUY
$13.37 - $17.79 $30,657 - $40,792
2,293 Added 13.38%
19,430 $316,000
Q4 2021

Feb 02, 2022

SELL
$14.28 - $19.53 $642 - $878
-45 Reduced 0.26%
17,137 $279,000
Q3 2021

Nov 02, 2021

SELL
$12.99 - $20.47 $87,383 - $137,701
-6,727 Reduced 28.14%
17,182 $255,000
Q2 2021

Aug 02, 2021

BUY
$15.46 - $24.5 $3,231 - $5,120
209 Added 0.88%
23,909 $477,000
Q4 2020

Feb 08, 2021

SELL
$24.48 - $42.47 $169,964 - $294,869
-6,943 Reduced 22.66%
23,700 $585,000
Q2 2020

Aug 07, 2020

BUY
$46.7 - $92.04 $61,036 - $120,296
1,307 Added 4.46%
30,643 $1.47 Million
Q1 2020

May 06, 2020

BUY
$48.35 - $118.68 $52,169 - $128,055
1,079 Added 3.82%
29,336 $1.85 Million
Q4 2019

Feb 05, 2020

SELL
$57.36 - $124.1 $148,734 - $321,791
-2,593 Reduced 8.41%
28,257 $3.5 Million
Q3 2019

Nov 07, 2019

BUY
$58.69 - $80.46 $120,314 - $164,943
2,050 Added 7.12%
30,850 $2.05 Million
Q2 2019

Aug 09, 2019

BUY
$77.77 - $120.68 $206,090 - $319,802
2,650 Added 10.13%
28,800 $2.29 Million
Q1 2019

May 08, 2019

BUY
$91.83 - $120.68 $335,179 - $440,482
3,650 Added 16.22%
26,150 $2.93 Million
Q4 2018

Feb 08, 2019

SELL
$85.79 - $126.46 $171,580 - $252,920
-2,000 Reduced 8.16%
22,500 $2.27 Million
Q3 2018

Nov 07, 2018

BUY
$88.49 - $127.55 $8,849 - $12,755
100 Added 0.41%
24,500 $3.1 Million
Q2 2018

Aug 10, 2018

SELL
$60.0 - $85.67 $954,000 - $1.36 Million
-15,900 Reduced 39.45%
24,400 $2.05 Million
Q2 2017

Aug 11, 2017

BUY
N/A
40,300
40,300 $4.88 Million

Others Institutions Holding ICPT

About INTERCEPT PHARMACEUTICALS, INC.


  • Ticker ICPT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,127,400
  • Description
  • Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...
More about ICPT
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.